Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.
2026-02-23 01:35:00 ET
Software stocks have gotten obliterated in recent weeks due to fears over artificial intelligence ( AI ) disruption. Some stocks have now fallen 50% in just a few short months. This is creating buying opportunities for high-quality businesses that are being thrown out with the bathwater.
One such stock with a lock on a profitable niche in the United States is Doximity (NYSE: DOCS) . The social feed and software provider for doctors has seen its stock fall by 66% in the past year and now trades close to an all-time low. However, if you look at the underlying business, it is doing just fine.
Here's why the software provider may be a great healthcare compounder investors can buy today.
NASDAQ: DOCS
DOCS Trading
-1.11% G/L:
$24.99 Last:
1,138,989 Volume:
$25.37 Open:
